Carta científico-clínica
Erupción dermatomiositis-like asociada al tratamiento con hidroxiurea: ¿una entidad premaligna?
Dermatomyositis-Like Eruption Associated With Hydroxyurea Therapy: A Premalignant Condition?
Leído
9127
Vecesse ha leído el artículo
2903
Total PDF
6224
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 21 | 10 | 31 |
| 2025 5 | 140 | 48 | 188 |
| 2025 4 | 146 | 40 | 186 |
| 2025 3 | 121 | 18 | 139 |
| 2025 2 | 173 | 33 | 206 |
| 2025 1 | 87 | 26 | 113 |
| 2024 12 | 97 | 32 | 129 |
| 2024 11 | 74 | 55 | 129 |
| 2024 10 | 93 | 47 | 140 |
| 2024 9 | 82 | 25 | 107 |
| 2024 8 | 102 | 54 | 156 |
| 2024 7 | 109 | 24 | 133 |
| 2024 6 | 89 | 39 | 128 |
| 2024 5 | 74 | 28 | 102 |
| 2024 4 | 84 | 29 | 113 |
| 2024 3 | 71 | 25 | 96 |
| 2024 2 | 54 | 29 | 83 |
| 2024 1 | 68 | 26 | 94 |
| 2023 12 | 65 | 16 | 81 |
| 2023 11 | 58 | 22 | 80 |
| 2023 10 | 60 | 24 | 84 |
| 2023 9 | 73 | 34 | 107 |
| 2023 8 | 77 | 16 | 93 |
| 2023 7 | 136 | 39 | 175 |
| 2023 6 | 103 | 18 | 121 |
| 2023 5 | 122 | 26 | 148 |
| 2023 4 | 144 | 20 | 164 |
| 2023 3 | 116 | 22 | 138 |
| 2023 2 | 99 | 36 | 135 |
| 2022 1 | 89 | 33 | 122 |
| 2022 12 | 95 | 32 | 127 |
| 2022 11 | 132 | 42 | 174 |
| 2022 10 | 115 | 41 | 156 |
| 2022 9 | 117 | 53 | 170 |
| 2022 8 | 101 | 50 | 151 |
| 2022 7 | 107 | 54 | 161 |
| 2022 6 | 86 | 28 | 114 |
| 2022 5 | 92 | 44 | 136 |
| 2022 4 | 74 | 39 | 113 |
| 2022 3 | 68 | 66 | 134 |
| 2022 2 | 45 | 30 | 75 |
| 2021 1 | 82 | 54 | 136 |
| 2021 12 | 56 | 54 | 110 |
| 2021 11 | 64 | 48 | 112 |
| 2021 10 | 65 | 62 | 127 |
| 2021 9 | 48 | 43 | 91 |
| 2021 8 | 54 | 28 | 82 |
| 2021 7 | 50 | 40 | 90 |
| 2021 6 | 45 | 50 | 95 |
| 2021 5 | 39 | 26 | 65 |
| 2021 4 | 88 | 97 | 185 |
| 2021 3 | 60 | 28 | 88 |
| 2021 2 | 78 | 36 | 114 |
| 2020 1 | 47 | 28 | 75 |
| 2020 12 | 58 | 26 | 84 |
| 2020 11 | 33 | 21 | 54 |
| 2020 10 | 52 | 18 | 70 |
| 2020 9 | 38 | 10 | 48 |
| 2020 8 | 36 | 29 | 65 |
| 2020 7 | 41 | 18 | 59 |
| 2020 6 | 39 | 20 | 59 |
| 2020 5 | 42 | 33 | 75 |
| 2020 4 | 40 | 28 | 68 |
| 2020 3 | 37 | 39 | 76 |
| 2020 2 | 7 | 6 | 13 |
| 2020 1 | 6 | 5 | 11 |
| 2019 12 | 10 | 10 | 20 |
| 2019 11 | 4 | 6 | 10 |
| 2019 10 | 0 | 8 | 8 |
| 2019 9 | 4 | 8 | 12 |
| 2019 8 | 4 | 6 | 10 |
| 2019 7 | 4 | 11 | 15 |
| 2019 6 | 4 | 34 | 38 |
| 2019 5 | 6 | 52 | 58 |
| 2019 4 | 3 | 37 | 40 |
| 2019 3 | 4 | 17 | 21 |
| 2019 2 | 0 | 12 | 12 |
| 2019 1 | 9 | 21 | 30 |
| 2018 12 | 4 | 6 | 10 |
| 2018 11 | 3 | 13 | 16 |
| 2018 10 | 2 | 4 | 6 |
| 2018 9 | 3 | 3 | 6 |
| 2018 8 | 0 | 18 | 18 |
| 2018 7 | 0 | 6 | 6 |
| 2018 6 | 0 | 5 | 5 |
| 2018 5 | 0 | 11 | 11 |
| 2018 4 | 1 | 13 | 14 |
| 2018 3 | 0 | 2 | 2 |
| 2018 2 | 72 | 8 | 80 |
| 2018 1 | 97 | 14 | 111 |
| 2017 12 | 82 | 12 | 94 |
| 2017 11 | 39 | 12 | 51 |
| 2017 10 | 30 | 13 | 43 |
| 2017 9 | 41 | 14 | 55 |
| 2017 8 | 30 | 13 | 43 |
| 2017 7 | 26 | 11 | 37 |
| 2017 6 | 47 | 20 | 67 |
| 2017 5 | 32 | 7 | 39 |
| 2017 4 | 33 | 14 | 47 |
| 2017 3 | 47 | 42 | 89 |
| 2017 2 | 43 | 15 | 58 |
| 2016 1 | 24 | 10 | 34 |
| 2016 12 | 51 | 19 | 70 |
| 2016 11 | 76 | 21 | 97 |
| 2016 10 | 9 | 3 | 12 |
| 2016 9 | 1 | 9 | 10 |
| 2016 8 | 0 | 4 | 4 |
| 2016 7 | 4 | 1 | 5 |
| 2016 6 | 7 | 12 | 19 |
| 2016 5 | 11 | 10 | 21 |
| 2016 4 | 10 | 3 | 13 |
| 2016 3 | 6 | 4 | 10 |
| 2016 2 | 9 | 3 | 12 |
| 2015 1 | 18 | 5 | 23 |
| 2015 12 | 18 | 4 | 22 |
| 2015 11 | 13 | 3 | 16 |
| 2015 10 | 17 | 1 | 18 |
| 2015 9 | 18 | 2 | 20 |
| 2015 8 | 11 | 3 | 14 |
| 2015 7 | 32 | 7 | 39 |
| 2015 6 | 27 | 4 | 31 |
| 2015 5 | 31 | 6 | 37 |
| 2015 4 | 13 | 10 | 23 |
| 2015 3 | 17 | 7 | 24 |
| 2015 2 | 21 | 9 | 30 |
| 2015 1 | 8 | 5 | 13 |
| 2014 12 | 4 | 5 | 9 |
| 2014 11 | 18 | 14 | 32 |
| 2014 10 | 2 | 1 | 3 |
Mostrar todo
